<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We sought to determine the in-hospital incidence and predictors of ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients with ST elevation <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e>) undergoing primary percutaneous coronary intervention (PCI) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We reviewed 2638 consecutive patients undergoing 2722 pimary PCI procedures for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> during in-hospital stay </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> was defined as any new focal neurological deficit lasting &gt; or =24 h, occurring anytime during or after PCI until discharge </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with haemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> were excluded </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical characteristics and in-hospital outcome were analysed regarding ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients undergoing primary PCI </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> was observed in 20 of the 2722 procedures, an incidence of 0.73% </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> were older than patients without <z:hpo ids='HP_0001297'>stroke</z:hpo> (mean age 67 +/- 9.6 vs. 56.6 +/- 11.8, P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to patients without <z:hpo ids='HP_0001297'>stroke</z:hpo>, female gender, <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> were more prevalent in patients with <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> was found to be a powerful independent predictor of in-hospital cardiovascular mortality (odds ratio [OR] 6.32, 1.15-34.7; P &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>Left ventricular ejection fraction (LVEF) &lt; 35% (OR 3.13, P = 0.04), contrast-induced <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (OR 2.91, P = 0.04) and <z:chebi fb="0" ids="9605">tirofiban</z:chebi> use (OR 0.23, P = 0.02) were the independent predictors for in-hospital ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The present study shows that the incidence of ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients undergoing PCI for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> is higher and ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> increases in-hospital mortality in these patients </plain></SENT>
<SENT sid="11" pm="."><plain>Moreover, LVEF &lt; 35% and contrast-induced <z:hpo ids='HP_0000112'>nephropathy</z:hpo> were independent predictors of ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo>, whereas <z:chebi fb="0" ids="9605">tirofiban</z:chebi> use demonstrated a protective effect to this potentially catastrophic complication </plain></SENT>
</text></document>